RECRUITINGOBSERVATIONAL

The Homburg Keratoconus Center (HKC)

The Homburg Keratoconus Center (HKC) - a Keratoconus Observation Study

About This Trial

Aim of this study is to conduct longitudinal and cross-sectional analyses about the corneal ectatic disease Keratoconus based on data obtained from Keratoconus patients in the Homburg Keratoconus Center (HKC). The Homburg Keratoconus Center (HKC) was founded in 2010 and, up to now, comprises more than 3,000 Keratoconus patients. Topographic, tomographic and biomechanic characteristics of the disease are being analyzed with the intention to elucidate how the disease begins and develops during lifetime.

Who May Be Eligible (Plain English)

Who May Qualify: - All Keratoconus patients presenting in the department of ophthalmology, Saarland University Medical Center, Homburg, Saarland, Germany. Who Should NOT Join This Trial: - Patients without Keratoconus. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * All Keratoconus patients presenting in the department of ophthalmology, Saarland University Medical Center, Homburg, Saarland, Germany. Exclusion Criteria: * Patients without Keratoconus.

Treatments Being Tested

DIAGNOSTIC_TEST

Topographic, tomographic and biomechanical analysis.

The study is based upon data obtained during routine medical follow-ups using 1. the Pentacam high resolution (Oculus, Wetzlar, Germany) 2. the Corvis ST (Oculus, Wetzlar, Germany) 3. the Anterior-Segment Optical Coherence Tomograph (AS-OCT) Casia 2 (Tomey, Nagoya, Japan) 4. the Ocular Response Analyzer (Reichert Technologies, New York, USA).

Locations (1)

Department of Ophthalmology

Homburg, Saarland, Germany